DeutschNewstral
Article
Mmarketwatch.com on 2016-11-09 22:59
Alexion Pharma shares halted, company to delay quarterly results
Related news
- MPeregrine Pharma shares drop after quarterly results fall shortmarketwatch.com
Alexion Pharma to pay $8.4 billion for SynagevaThe Salt Lake Tribune- MAlexion Pharma pauses further enrollment in COVID-19 drug studymarketwatch.com
Alexion Pharma to pay $8.4 billion for Synageva BioPharmaabc3340.com
Alexion Pharma to pay $8.4B for Synageva BioPharmaseattletimes.com- MCosi shares halted after CEO oustermarketwatch.com
- MExpedia shares slide on disappointing quarterly earningsmarketwatch.com
- MOclaro shares jump 20% on quarterly outlookmarketwatch.com
- MHartford shares drop after quarterly earnings missmarketwatch.com
- MFedex shares slide following quarterly lossmarketwatch.com
- MStamps.com shares jump after quarterly results beatmarketwatch.com
- MTripAdvisor shares fall after quarterly results missmarketwatch.com
- MAlexion shares fall after drug study fails to reach main goalmarketwatch.com
- MAbiomed gets heart-pump FDA approval, shares haltedmarketwatch.com
- MFive9 shares rally as quarterly results top Wall Street viewmarketwatch.com
- MMellanox shares fall as quarterly results, outlook miss Street viewmarketwatch.com
- MHP shares gain on in-line quarterly earningsmarketwatch.com
- MZumiez shares up 12% on better quarterly outlookmarketwatch.com